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Background: After treatment for breast cancer, most women receive an annual surveillance 
mammography to look for subsequent breast cancers. Supplemental breast MRI is sometimes 
used in addition to mammography despite the lack of clinical evidence for it. Breast imaging 
after cancer treatment is an emotionally charged experience, an important part of survivorship 
care, and a topic about which limited patient information exists. We assessed women’s experi-
ences and preferences about breast cancer surveillance imaging with the goal of determining 
where gaps in care and knowledge could be filled.
Participants and methods: We conducted six focus groups with a convenience sample of 
41 women in California, North Carolina, and New Hampshire (USA). Participants were aged 
38–75 years, had experienced stage 0–III breast cancer within the previous 5 years, and had 
completed initial treatment. We used inductive thematic analysis to identify key themes from 
verbatim transcripts.
Results: Women reported various types and frequencies of surveillance imaging and a range 
of surveillance imaging experiences and preferences. Many women experienced discomfort 
during breast imaging and anxiety related to the examination, primarily because they feared 
subsequent cancer detection. Women reported trust in their providers and relied on providers 
for imaging decision-making. However, women wanted more information about the treatment 
surveillance transition to improve their care.
Conclusion: There is significant opportunity in breast cancer survivorship care to improve 
women’s understanding about breast cancer surveillance imaging and to provide enhanced 
support to them at the time their initial treatment ends and at the time of surveillance imag-
ing examinations.
Keywords: breast cancer surveillance, mammography, breast MRI, cancer survivorship, 
oncology
Introduction
For women with a history of breast cancer, finishing initial treatment is a significant 
milestone; whether it involves the last radiation session, the final chemotherapy 
infusion, or surgery. The subsequent period of breast cancer care is known as the 
“surveillance period,” a time when women see their care providers for follow-up visits 
and imaging to monitor for subsequent breast cancers.
According to national guidelines, women treated for breast cancer are recommended 
to receive annual mammograms in the absence of new signs or symptoms within 
6 to 12 months after the completion of initial treatment and annually thereafter.1,2 
While no formal guidelines recommend breast magnetic resonance imaging (MRI) 
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for breast cancer surveillance, some providers recommend 
breast MRI as an adjunct to mammography.3
Women’s experiences with surveillance breast imaging 
are important to understand from both the patient and clinical 
perspectives. Carlos et al4 suggested that patient-centered 
outcomes in radiology should focus on a patient’s experience 
of care beyond traditional measures of satisfaction. Specifi-
cally, they should include additional measures of benefits and 
harms, on outcomes relevant to women, and provide informa-
tion to inform decision-making. Examining patient perspec-
tives could help improve cancer survivorship planning and 
overall adherence to breast imaging recommendations.
Few studies have examined patient perspectives regarding 
imaging for cancer after completing treatment. In one prior 
study with adults who were diagnosed with various cancers, 
including early-stage breast cancer, participants reported high 
levels of gratitude for imaging tests that could be lifesaving; 
however, they often reported not understanding or receiving 
clear communication about the reasons for surveillance imag-
ing from providers.5 In another study that included women 
without a history of breast cancer but who had experienced a 
false-positive result from breast imaging, more than half the 
participants reported being “scared” or “stressed” about mam-
mography.6 We were unable to identify any studies focused 
on women’s experiences or feelings about mammography or 
breast MRI used for surveillance imaging after completing the 
treatment for breast cancer. Given that there are .2.9 million 
breast cancer survivors in the US,7 there is a need to better 
understand and potentially improve women’s perspectives 
about and experiences with surveillance imaging. Thus, we 
assessed women’s experiences and preferences about breast 
cancer surveillance imaging with the goal of determining 
where gaps in care and knowledge could be filled by conduct-
ing a qualitative study of women with prior breast cancer in 
different geographic regions of the US.
Materials and methods
Participant recruitment
We conducted six focus groups among women in California, 
North Carolina, and New Hampshire, where there are Breast 
Cancer Surveillance Consortium (BCSC) registries with 
ongoing data collection systems.8 The BCSC is a collabora-
tive network of breast imaging registries that began in 1994 
with the goal of assessing the delivery and quality of breast 
imaging and related outcomes in the US.8 Each registry 
recruited women by mail and telephone to participate in the 
focus groups as a convenience-based sample either among 
those who had received a mammogram at facilities that 
contribute to that registry and had granted permission to be 
recontacted or through a local cancer registry.
Eligible women were aged 18–75 years with a history of 
American Joint Committee on Cancer (AJCC) stage 0–III 
breast cancer diagnosed within the prior 5 years. Eligible 
women must have completed initial treatment for breast cancer 
(ie, surgery, chemotherapy, and/or radiation), but could be still 
taking adjuvant hormone therapy. Women were screened by 
telephone to ensure that they met the eligibility criteria. No 
individual risk factor or race/ethnicity data were collected. 
Two focus groups were conducted per geographic site. A mean 
number of seven women participated per group.
Institutional review board approval for this study was 
obtained from the following participating institutions: the 
University of California, San Francisco, the University of 
North Carolina, Chapel Hill, and Dartmouth College. All 
women provided written informed consent prior to focus 
group participation.
interviewing and data collection
The six focus groups were led by the same facilitator who 
has 20+ years of experience conducting research interviews 
and facilitating focus groups. The principal investigator and 
at least one patient partner from the study team also attended 
each focus group. The patient partners served as an important 
bridge to participants and were present to ease social dis-
comfort. They also provided their impressions of the focus 
group content after the discussions, a pivotal contribution 
to the overall role that they played in this study.9 During 
the 2-hour discussions, we used a semistructured interview 
guide to ensure consistency but flexibility for each focus 
group. The guide, used to elicit participant’s experiences and 
feelings about surveillance breast imaging, was developed 
from preparatory focus groups conducted as part of the grant 
development process and from input from patient partners, 
researchers, and clinicians on the study team. Verbatim 
written transcripts were generated by a confidentiality-bound 
stenographer present at each discussion.
Analysis
We used a combination of deductive and inductive thematic 
analysis10 to develop themes and subthemes that emerged 
from the discussions among our three-person coding team 
(SB, DER, and KJW). Coders had backgrounds in social 
and behavioral sciences and health services (SB), clinical 
psychology and health promotion (DER), and epidemiology 
and patient-involved research methods (KJW). The coders 
discussed emergent themes from initial individual reviews, 
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which were used to develop a preliminary codebook and 
definitions. This codebook was used for the remaining four 
transcripts. Once all transcripts were coded, the team met 
to compare codes and reconcile discrepancies. Qualitative 
software Atlas.ti version 7.5.2 was used to organize final 
codes into themes.
Results
Forty-one women with prior breast cancer aged 38–75 years 
participated in the focus groups. Breast cancer stage at the 
time of diagnosis were stage 0: n=4 (9.8%), stage I: n=14 
(34.1%), stage II: n=18 (43.9%), stage III: n=3 (7.3%), and 
unknown: n=2 (,1%).
The discussion yielded feedback on the following four 
overarching themes: 1) type and frequency of surveillance 
breast imaging, 2) surveillance imaging experiences and 
preferences, 3) trust in providers, and 4) knowledge and 
decision-making about surveillance imaging.
Theme 1: type and frequency of  
surveillance breast imaging
Women reported varied surveillance imaging patterns of 
mammography and breast MRI. Almost all women received 
mammography. Some women also received breast MRI. 
The most commonly reported pattern of surveillance breast 
imaging after completing breast cancer treatment was mam-
mography every 3 or 6 months for 1 to 3 years after comple-
tion of treatment. Subsequently, most women reported having 
surveillance imaging either annually or every 6 months with 
a staggered pattern for those receiving mammography plus 
adjunct breast MRI. Most participants reported that either 
their oncologist or surgeon recommended and made the refer-
rals for their imaging type and frequency after treatment. In a 
few cases, their primary care provider played this role.
Theme 2: surveillance imaging 
experiences and preferences
Women shared their imaging experiences and preferences, 
including being on a standardized imaging schedule, wanting 
the experience to be as painless as possible, and concern 
about subsequent breast cancers. Some women had either 
physically or emotionally negative breast imaging experi-
ences. Many women experienced high levels of anxiety 
about and dislike for breast imaging, either because the test 
reminded them of their initial breast cancer diagnosis or 
because they feared having breast cancer again.
I dread it for a couple of weeks before. My anxiety builds 
as I get closer to the date.
I had to find the right dose for Ativan just to get me 
comfortable enough to get my boobies in there.
Another important aspect of the participants’ experience 
focused on the discomfort of the imaging procedure. Some 
reported that radiology facilities actively tried to make them 
more comfortable either by being emotionally supportive or 
by providing warm blankets or pads to buffer the edge of the 
equipment. However, many women stated that mammogra-
phy was painful or cold, or that staff were not empathetic. 
A few women had adverse reactions to the contrast dye 
injected during breast MRI. Others reported the procedure 
to be uncomfortable because of the position they had to hold 
or claustrophobia.
She puts this pink foam on the platform of the thing, and it 
just cushions everything. 
You have to situate to the machine in order to get the image, 
and it’s uncomfortable, and not only is it uncomfortable, 
it’s dehumanizing.
Many women disliked the waiting period between 
completion of examination and receiving test results because 
the experience reminded them of when they were first evalu-
ated for breast cancer. They said they felt stressed until they 
received their imaging results.
The worst point is between when you do your initial 
images and then you’re waiting to see if you need more 
images. Because then as soon as they ask for more images, 
the mind just goes crazy about what they found and what 
they see.
She [provider] came in with her files close to her chest – is 
she holding it close to her chest because she’s going to tell 
me something terrible?
Although some women were satisfied with the frequency 
of their imaging, others wanted imaging more often for reas-
surance that they did not have breast cancer again. A few 
women were concerned about receiving breast imaging too 
often because of radiation exposure from mammography or 
the invasiveness of imaging.
I feel good about my schedule. 
If we had a safer imaging technique, I would get it twice, 
three times a year.
I’m not really educated about what kind of radiation you 
get from the mammographies and if it’s something I should 
be concerned with.
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A portion of the discussion was dedicated to discussing 
experiences and feeling about false-positive and false-
negative results. Some women stated that they would prefer 
a false-positive result with follow-up procedures, such as 
a biopsy, and be reassured that they did not have another 
breast cancer than have a cancer be missed. However, other 
women wanted to avoid false-positive results and follow-up 
procedures because the additional tests caused too much 
worry, physical discomfort, and potential expense.
I would rather deal with the false positives than miss some-
thing, or think I might miss something.
I want something to be so definite right away and not to 
have any issues, no false positives, nothing. I want to 
know, and I want to know now, and I realize that’s not 
possible.
Another important subtheme was the array of trust in the 
imaging modality. Some women whose breast cancer was not 
found with screening mammography had less trust in mam-
mography. Other women were confident in mammography 
and did not feel the need for reassurance from additional 
imaging modalities.
I’m not totally sold about the mammograms, seeing how 
I had a perfectly normal mammogram four months before 
being diagnosed with breast cancer. 
I’m now at the once a year both, every six months one. I 
feel like this is good. I feel good about continuing to get 
mammograms.
Theme 3: trust in providers
Many participants reported having complete trust in pro-
viders and therefore followed given recommendations. 
They felt their providers were sufficiently trained on the 
current recommendations for surveillance breast imaging. 
Some women mentioned that they sometimes asked ques-
tions about a provider’s clinical choices, despite such 
inquiries being intimidating. A few women voiced distrust 
of provider motivations for their clinical decision-making 
regarding surveillance breast imaging, questioning whether 
decisions were being based on financial incentives rather 
than clinical impressions.
You have to trust your doctor. That’s it. You have to trust 
that they know what they’re doing. 
I’ve learned over time that I have to ask her questions and 
my doctor, she’s well known for the type I have, but she is 
so smart that I sometimes keep quiet and don’t say anything. 
And I realize now, no, no, no, I don’t care how stupid I 
look, I’m going to ask her. 
I’ve begged my oncologist, I’m like, ‘I want an MRI.’ And 
my oncologist says, ‘The mammogram did its job. Your 
cancer was found on the mammogram. We will continue 
with surveillance with mammography, unless you have a 
problem.
Theme 4: knowledge and decision-making 
about surveillance
Most participants had never heard the term “surveillance” 
prior to the focus groups. Nonetheless, they remembered the 
time when their initial treatment, such as chemotherapy or 
radiation, ended. Some expressed that they were not given 
clear information about what follow-up care they would 
need in the short- or long-term future. Others had received 
a straightforward, detailed survivorship care plan.
To me it seems like there is a logistical handoff problem – 
more knowledge is better. I would have, of course, liked a 
handout about that and everything else that I would need 
to know about. 
I was told from the beginning that I would have to have 
yearly mammograms, just on the right side – they really 
make it very easy to do the whole follow-up.
Even with the offering of annual mammography, many 
of the women felt they did not have sufficient information 
to participate in decision-making about breast imaging after 
their treatment. Some women chose not to engage in imaging 
discussions with their providers. Women reported feeling 
confusion about the choices for surveillance imaging or 
about the frequency of imaging examinations. Other women 
reported more active involvement in decision-making about 
breast imaging, either because their provider initiated such 
discussions or because they actively sought it themselves.
Decision-making is really hard. You’re presented with all 
of these things. And I kept saying I’m not a doctor, I don’t 
know. I don’t know. You know, what should I do? What 
is the right course?
 My oncologist let me change to just mammograms every 
six months without the MRI. I like her manner. She says 
what she believes is the best, but then she doesn’t argue or 
make you feel badly if you want to do something else, but 
the thing is, of course, she is the expert.
Finally, cost and insurance coverage was an important 
topic that sometimes affected participant preferences and 
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experiences with surveillance imaging. Costs associated with 
copays or deductibles were a concern regarding surveillance 
breast imaging for some women, while for other women, 
cost was not a concern or barrier because she had insurance 
coverage or could afford to pay out of pocket costs.
The MRI scan – I didn’t know was going to cost so much 
money. If I had known ahead of time, I might have made 
a different decision.
I would say that health care is really high on my list of 
priorities. When it comes to TV, I have limited basic. But 
health care. If I spend a couple of thousand dollars a year 
out of my pocket on health care, that’s fine. I would rather 
do that than go to Puerto Vallarta for a week.
Discussion
This study validated that there is a wide range of radiology 
practices pertaining to breast cancer surveillance in the US, 
despite national guidelines recommending annual mammo-
graphy. It also revealed that women experience the process of 
surveillance breast imaging in various positive and negative 
ways. Most importantly, it revealed areas in which patient 
care and clinical decision-making can be improved in order 
to be more educational and comfortable for women.
Several themes arose inductively that were not explicitly 
assessed via our interview guide. Many women expressed 
intense worry at the time of surveillance imaging because 
they feared having breast cancer again. The worries 
expressed by cancer survivors are well documented in prior 
literature.11–13 Schonberg et al14 determined that 44% of 
women with prior breast cancer experience anxiety about 
future mammograms. We believe that the pervasive, although 
not unanimous, acceptance of false-positive recall and high 
anxiety associated with imaging examinations were indica-
tors that women might be overestimating their risk of cancer 
second breast cancer events. Fardell et al15 highlight the 
dearth of information available to women about their risk 
of subsequent breast cancers, calling for improved tools to 
manage this fear.
Women reported high levels of provider trust and did 
not often question their imaging recommendations. It was 
not clear whether providers were recommending imaging 
regimens based on clinical guidelines, clinical autonomy, or 
institutional policy. This topic warrants further exploration. 
Given the various reported experiences and recommenda-
tions, clarifying justification for imaging recommendations 
will likely help to alleviate some women’s fear and increase 
understanding of surveillance breast imaging modalities.
Radiology facilities have the opportunity to improve 
breast imaging experiences for all women, not just women 
with prior breast cancer. Women reported wanting provid-
ers and facilities to make mammography and breast MRI 
more physically and emotionally comfortable including 
same day reporting of results within a short time, especially 
in light of their breast cancer history. One study found that 
women had a better experience with breast MRI than with 
mammography but also emphasized the importance of the 
facility’s sensitivity to women’s needs and their experience 
conducting the imaging as being a high priority regardless 
of imaging modality.16
While our study adds to the literature and has consider-
able strengths, such as the geographically diverse sample 
with various cancer stages, it has limitations. First, the 
women were all insured, able to attend a weekday focus 
group, and were not proportionately racially diverse to the 
US population. Therefore, we may not have obtained key 
issues related to health care decision-making and access 
in underserved and underrepresented populations. Second, 
we did not collect information regarding breast cancer risk 
factors, including genetic mutations, family history, or breast 
density, elements that could have influenced surveillance 
preferences and experiences. Third, we included a highly 
heterogeneous sample by age at diagnosis and stage of breast 
cancer. These two factors can drive clinical decision-making 
about surveillance imaging and thus may explain some of 
the deviation we heard regarding adherence to surveillance 
imaging guidelines. Despite these limitations, our study pro-
vides important new information previously lacking in the 
literature. There is significant opportunity in breast cancer 
survivorship care to improve women’s understanding about 
breast cancer surveillance imaging, to provide enhanced 
psychological support at the time their initial treatment ends 
and continue that support at the time of surveillance imag-
ing examinations.
Conclusion
There is scant research that has examined women’s perspec-
tives about breast cancer surveillance imaging. Our results 
suggest that women treated for stage 0–III breast cancer 
within 5 years of diagnosis have diverse experiences and 
feelings regarding surveillance breast imaging. Due to the 
large number of breast cancer survivors who receive annual 
surveillance mammograms in the US, improving processes 
to more robustly support the psychological and physical 
experience of breast cancer surveillance imaging is important 
for survivorship care.
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Our study also reveals that, although annual surveillance 
mammography is the guideline standard,2 some women 
undergo adjunct surveillance breast MRI too. Additionally, 
many women in our study received surveillance mammogra-
phy more often than annually following treatment despite the 
absence of signs or symptoms. These reported surveillance 
patterns suggest an opportunity in clinical care to either better 
align imaging practices with national guidelines or inform 
women about reasons for deviations from guidelines.
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